30 results about "Bergamottin" patented technology

A metabolic syndrome-improving agent that does not have a side effect problem and can be taken for a long period of time is provided. Bergamottin is used as the metabolic syndrome-improving agent. Because bergamottin has a PPAR a and activating action, an adiponectin secretion promoting action in an adipocyte and a VLDL synthesis inhibiting action in a liver cell, the prevention, treatment or thelike of a disease such as insulin resistance, hyperinsulinemia, type 2 diabetes mellitus, obesity, visceral fat accumulation, hypertension, hyperlipidemia or arteriosclerosis is possible, whereby theprevention, treatment or the like of metabolic syndrome is possible. Because citrus that contains bergamottin such as grapefruit has been eaten for a long time, there is no problem concerning safety,and in addition, it is low in calories, therefore it can be taken for a long period of time. Because bergamottin is tasteless and odorless, even if it is added to food, it does not destroy the specific flavor of the food. Therefore, it can be taken by adding it to food.

The invention discloses a Chinese traditional medicine soup used for treating chronic gastritis, belonging to the Chinese traditional medicine field. The active ingredients of the Chinese traditionalmedicine soup used for treating chronic gastritis are prepared by the following raw materials by weight: 15g of baked radix astragali,12g of baked liquorice, 10g of white peony, 10g of angelica, 10g of radix codonopsitis, 10g of berganmot ,10g of green tangerine orange peel , 15g of largehead atractylodes rhizome, 20g of dendrobe, 20g of root of rehmannia and 3g of radix bupleuri. The medicine rawmaterials are boiled and taken with water, with one dose per day and twice taking per dose. Continious oral administration for ten days is a treatment period. By mixing the raw materials, the invention can achieve synergetic effect, so remarkable effect can be seen during the treatment of chronic gastritis.

Compositions and methods for the prevention and treatment of anxiety conditions associated with the use of cannabis are disclosed herein. The medicinal compositions include cannabidiol or cannabidiolic acid and one or more of the following compounds: bergamottin or dihydroxybergamottin, phloretin or a phloretin glycoside, piperine, apigenin or an apigenin glycoside and ursolic acid.